These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17628675)

  • 1. Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.
    Gould TD; Einat H
    Neurosci Biobehav Rev; 2007; 31(6):825-31. PubMed ID: 17628675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of bipolar disorder.
    Kato T; Kubota M; Kasahara T
    Neurosci Biobehav Rev; 2007; 31(6):832-42. PubMed ID: 17466374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and mood stabilization in bipolar disorder.
    Ruzickova M; Turecki G; Alda M
    Am J Med Genet C Semin Med Genet; 2003 Nov; 123C(1):18-25. PubMed ID: 14601033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for screening new agents: a behavioural view.
    Kumar R
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):13-7. PubMed ID: 973944
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Animal models for evaluating psychotropic drugs.
    Kumar R
    Psychol Med; 1974 Nov; 4(4):353-9. PubMed ID: 4477395
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
    Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
    Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders.
    Rass O; Krishnan G; Brenner CA; Hetrick WP; Merrill CC; Shekhar A; O'Donnell BF
    Bipolar Disord; 2010 Dec; 12(8):793-803. PubMed ID: 21176026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neural effects of psychotropic medications in children and adolescents.
    Singh MK; Chang KD
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):753-71. PubMed ID: 23040900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of mood disorders: Recent developments.
    Cryan JF; Slattery DA
    Curr Opin Psychiatry; 2007 Jan; 20(1):1-7. PubMed ID: 17143074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.
    Fond G; Tinland A; Boucekine M; Girard V; Loubière S; Auquier P; Boyer L;
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():84-89. PubMed ID: 30153497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.
    Chang KD; Saxena K; Howe M; Simeonova D
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):25-32. PubMed ID: 20166793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives for the development of animal models of bipolar disorder.
    Machado-Vieira R; Kapczinski F; Soares JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):209-24. PubMed ID: 14751416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a Valid Animal Model of Bipolar Disorder: How the Research Domain Criteria Help Bridge the Clinical-Basic Science Divide.
    Cosgrove VE; Kelsoe JR; Suppes T
    Biol Psychiatry; 2016 Jan; 79(1):62-70. PubMed ID: 26531027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward constructing an endophenotype strategy for bipolar disorders.
    Hasler G; Drevets WC; Gould TD; Gottesman II; Manji HK
    Biol Psychiatry; 2006 Jul; 60(2):93-105. PubMed ID: 16406007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder.
    Wulsin LR; Blom TJ; Durling M; Welge JA; DelBello MP; Adler CM; McNamara RK; Strakowski SM
    Bipolar Disord; 2018 Nov; 20(7):658-665. PubMed ID: 29479787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.